Ten lessons learned from conducting an adherence intervention trial

Jeannie K Lee1, Karen A Grace3, Allen J Taylor31College of Pharmacy, University of Arizona, Tucson, AZ, USA; 2Department of Pharmacy, Walter Reed Army Medical Center, Washington DC, USA; 3Cardiology Division, Washington Hospital Center, Washington DC, USAAbstract: Clinical practice research provides...

Full description

Bibliographic Details
Main Authors: Jeannie K Lee, Karen A Grace, Allen J Taylor
Format: Article
Language:English
Published: Dove Medical Press 2009-04-01
Series:Patient Preference and Adherence
Online Access:http://www.dovepress.com/ten-lessons-learned-from-conducting-an-adherence-intervention-trial-a3020
id doaj-d2acf78bbfda42449dd7efbe03e6643d
record_format Article
spelling doaj-d2acf78bbfda42449dd7efbe03e6643d2020-11-24T22:03:12ZengDove Medical PressPatient Preference and Adherence1177-889X2009-04-012009default9398Ten lessons learned from conducting an adherence intervention trialJeannie K LeeKaren A GraceAllen J TaylorJeannie K Lee1, Karen A Grace3, Allen J Taylor31College of Pharmacy, University of Arizona, Tucson, AZ, USA; 2Department of Pharmacy, Walter Reed Army Medical Center, Washington DC, USA; 3Cardiology Division, Washington Hospital Center, Washington DC, USAAbstract: Clinical practice research provides a unique opportunity to care for a diverse patient population in various health care system settings. Federal study of Adherence to Medications in the Elderly (FAME) was the first prospective observational and randomized controlled trial to implement effective strategies to enhance medication adherence and health outcomes in older patients using polypharmacy. Ten lessons learned from conducting this adherence intervention trial are described: (1) Link the trial to existing clinical work, (2) Begin with a thorough understanding of medication adherence, (3) Ensure that trial highlights individualized intervention, (4) Tailor inclusion criteria and study duration to target population, (5) Employ a range of outcomes linked to meaningful clinical effects, (6) Win the support of the multidisciplinary team and the administration, (7) Promote team work, (8) Consider the potential limitations, (9) Seize the grant opportunities, and (10) Share the findings.Keywords: adherence, pharmacist, intervention, medication http://www.dovepress.com/ten-lessons-learned-from-conducting-an-adherence-intervention-trial-a3020
collection DOAJ
language English
format Article
sources DOAJ
author Jeannie K Lee
Karen A Grace
Allen J Taylor
spellingShingle Jeannie K Lee
Karen A Grace
Allen J Taylor
Ten lessons learned from conducting an adherence intervention trial
Patient Preference and Adherence
author_facet Jeannie K Lee
Karen A Grace
Allen J Taylor
author_sort Jeannie K Lee
title Ten lessons learned from conducting an adherence intervention trial
title_short Ten lessons learned from conducting an adherence intervention trial
title_full Ten lessons learned from conducting an adherence intervention trial
title_fullStr Ten lessons learned from conducting an adherence intervention trial
title_full_unstemmed Ten lessons learned from conducting an adherence intervention trial
title_sort ten lessons learned from conducting an adherence intervention trial
publisher Dove Medical Press
series Patient Preference and Adherence
issn 1177-889X
publishDate 2009-04-01
description Jeannie K Lee1, Karen A Grace3, Allen J Taylor31College of Pharmacy, University of Arizona, Tucson, AZ, USA; 2Department of Pharmacy, Walter Reed Army Medical Center, Washington DC, USA; 3Cardiology Division, Washington Hospital Center, Washington DC, USAAbstract: Clinical practice research provides a unique opportunity to care for a diverse patient population in various health care system settings. Federal study of Adherence to Medications in the Elderly (FAME) was the first prospective observational and randomized controlled trial to implement effective strategies to enhance medication adherence and health outcomes in older patients using polypharmacy. Ten lessons learned from conducting this adherence intervention trial are described: (1) Link the trial to existing clinical work, (2) Begin with a thorough understanding of medication adherence, (3) Ensure that trial highlights individualized intervention, (4) Tailor inclusion criteria and study duration to target population, (5) Employ a range of outcomes linked to meaningful clinical effects, (6) Win the support of the multidisciplinary team and the administration, (7) Promote team work, (8) Consider the potential limitations, (9) Seize the grant opportunities, and (10) Share the findings.Keywords: adherence, pharmacist, intervention, medication
url http://www.dovepress.com/ten-lessons-learned-from-conducting-an-adherence-intervention-trial-a3020
work_keys_str_mv AT jeannieklee tenlessonslearnedfromconductinganadherenceinterventiontrial
AT karenagrace tenlessonslearnedfromconductinganadherenceinterventiontrial
AT allenjtaylor tenlessonslearnedfromconductinganadherenceinterventiontrial
_version_ 1725832676417470464